Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 18, 2026
Researchers have identified molecular adhesives that shield insulin-producing cells from harm associated with diabetes. These findings hold promise for developing novel therapies to prevent or mitigate the progression of diabetes.
May 18, 2026
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes." ScienceDaily. ScienceDaily, 4 Ma...
May 18, 2026
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes." ScienceDaily. ScienceDaily, 4 Ma...
May 18, 2026
Researchers from the University of Kent have identified a skincare compound that demonstrates potent antibacterial properties against drug-resistant bacteria. This breakthrough discovery has significant implications for the development of novel treatments for infections caused by multidrug-resistant pathogens.
May 18, 2026
Researchers at the University of Kent have identified a compound found in skincare products that demonstrates potent antimicrobial activity against drug-resistant bacteria. This breakthrough discovery holds promise for the development of new treatments to combat antibiotic-resistant infections.
May 18, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 18, 2026
Researchers at the University of California - Santa Cruz have developed an innovative AI-powered smart bandage that significantly accelerates wound healing. The device has been shown to promote recovery 25% faster than traditional methods.
May 18, 2026
Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...
May 18, 2026
Researchers at Scripps Research Institute have made a significant discovery in enzyme engineering that could lead to novel therapies for Parkinson's disease, various cancers, and other protein-related disorders. This innovative approach has the potential to target diseases that were previously resistant to treatment.
